Manufacture
BioNTech Boosts CAR-T Manufacturing Prowess with Autolus Investment and mRNA Synergy
BioNTech, CAR-T, Manufacture, Investments, Autolus
AbbVie pours $223M into building out its biologics capacity in Singapore
Biological Factors, expansion, AbbVie, Capacity, Investments, Manufacture, Singapore